O. Bouché

Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findings

Stefan Kubicka, Richard Greil, Thierry André et al. · Annals of Oncology · 2013 · 103 citations · Full text

Medicine, Oncology, Pharmacotherapy +9

Multicentre phase II trial of capecitabine plus oxaliplatin (XELOX) in patients with advanced hepatocellular carcinoma: FFCD 03-03 trial

Valérie Boige, O. Bouché, J.-F. Blanc et al. · British Journal of Cancer · 2007 · 89 citations · Full text

Medicine, Oncology, Pharmacology +15

Phase III trial comparing initial chemoradiotherapy (intermittent cisplatin and infusional 5-FU) followed by gemcitabine vs. gemcitabine alone in patients with locally advanced non metastatic pancreatic cancer: A FFCD-SFRO study

Bruno Chauffert, F. Mornex, Franck Bonnetain et al. · Journal of Clinical Oncology · 2006 · 55 citations

Medicine, Oncology, Radiation Oncology +16

Bleeding reflux esophagitis: a prospective 1-year study in a university hospital

N Da Costa, Guillaume Cadiot, Corinne Merle et al. · The American Journal of Gastroenterology · 2001 · 23 citations

Medicine, Clinical Sciences, Internal Medicine +11

A Phase l/lI, Open-label, Randomised Study of BIBF 1120 Plus mFOLFOX6 Compared to Bevacizumab Plus mFOLFOX6 in Patients with Metastatic Colorectal Cancer

Eric Van Cutsem, Hans Prenen, Carmen Guillén‐Ponce et al. · European Journal of Cancer · 2011 · 22 citations

Medicine, Oncology, Pharmacology +6